107 related articles for article (PubMed ID: 24393986)
1. [Efficacy of oxaliplatin-based chemotherapy in Stage IV colorectal cancer patients with peritoneal carcinomatosis].
Hatano S; Matsuzawa T; Kumamoto K; Fukuchi M; Baba H; Kumagai Y; Ishibashi K; Haga N; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1981-3. PubMed ID: 24393986
[TBL] [Abstract][Full Text] [Related]
2. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
[TBL] [Abstract][Full Text] [Related]
3. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
4. [A case of peritoneal dissemination that exhibited a complete response to systemic chemotherapy following the resection of primary colon cancer].
Okamura S; Murata K; Wada Y; Kato R; Makino S; Ohwada Y; Nishigaki T; Murakami M; Okada K; Yanagisawa T; Ebisui C; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2270-2. PubMed ID: 23268046
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
6. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection.
Nitzkorski JR; Farma JM; Watson JC; Siripurapu V; Zhu F; Matteotti RS; Sigurdson ER
Ann Surg Oncol; 2012 Feb; 19(2):379-83. PubMed ID: 21861213
[TBL] [Abstract][Full Text] [Related]
7. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
Leung V; Huo YR; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Jan; 43(1):144-149. PubMed ID: 27780675
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change.
Bhandare M; Patil P; Pai V; Bhamre R; Engineer R; Ostwal V; Saklani A
Clin Colorectal Cancer; 2017 Jun; 16(2):e1-e6. PubMed ID: 27670895
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW
Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148
[TBL] [Abstract][Full Text] [Related]
12. Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.
Passot G; You B; Boschetti G; Fontaine J; Isaac S; Decullier E; Maurice C; Vaudoyer D; Gilly FN; Cotte E; Glehen O
Ann Surg Oncol; 2014 Aug; 21(8):2608-14. PubMed ID: 24668148
[TBL] [Abstract][Full Text] [Related]
13. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience.
Nikolic S; Dzodic R; Zegarac M; Djurisic I; Gavrilovic D; Vojinovic V; Kocic M; Santrac N; Radlovic P; Radosavljevic D; Pupic G; Martinovic A
J BUON; 2014; 19(1):66-74. PubMed ID: 24659645
[TBL] [Abstract][Full Text] [Related]
14. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
Robella M; Vaira M; De Simone M
World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.
Cashin PH; Mahteme H; Spång N; Syk I; Frödin JE; Torkzad M; Glimelius B; Graf W
Eur J Cancer; 2016 Jan; 53():155-62. PubMed ID: 26751236
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry.
Park YS; Ji J; Zalcberg JR; El-Serafi M; Buzaid A; Ghosn M
Asia Pac J Clin Oncol; 2015 Dec; 11(4):334-42. PubMed ID: 26471890
[TBL] [Abstract][Full Text] [Related]
18. Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
Ihemelandu C; Sugarbaker PH
Ann Surg Oncol; 2017 Apr; 24(4):898-905. PubMed ID: 27878480
[TBL] [Abstract][Full Text] [Related]
19. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
